Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 9/20 | 0.53 |
| ▸ | AGTR2 | P50052 | 9/20 | 0.53 |
| ▸ | GP6 | Q9HCN6 | 1/20 | 0.49 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.48 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.48 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.48 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9873306 | 0.93 | AGTR1 (0.50) | AGTR1AGTR2GP6ABCC4ABCB11 | |
| SCHEMBL9874627 | 0.87 | AGTR1 (0.53) | AGTR1AGTR2 | |
| SCHEMBL9872323 | 0.86 | AGTR1 (0.54) | AGTR1AGTR2 | |
| SCHEMBL9874616 | 0.86 | AGTR1 (0.54) | AGTR1AGTR2 | |
| SCHEMBL9873623 | 0.86 | AGTR1 (0.52) | AGTR1AGTR2 | |
| SCHEMBL9874104 | 0.86 | TLR7 (0.53) | AGTR1AGTR2 | |
| SCHEMBL9873526 | 0.86 | AGTR1 (0.52) | AGTR1AGTR2 | |
| SCHEMBL9874500 | 0.86 | AGTR1 (0.38) | AGTR1AGTR2GP6 | |
| SCHEMBL940 | 0.86 | GP6 (0.56) | AGTR1AGTR2GP6ABCC4ABCB11 | |
| SCHEMBL3347428 | 0.86 | GP6 (0.54) | AGTR1AGTR2GP6ABCC4ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1991019715-A1 | 1H-SUBSTITUTED-IMIDAZO[4,5-d]PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1991-12-26 | — | — | WO | claimed |
| WO-1991019715-A1 | 1H-SUBSTITUTED-IMIDAZO[4,5-d]PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1991-12-26 | — | — | WO | disclosed |